Is herpes zoster an additional complication in old age alongside comorbidity and multiple medications?
Antibacterial Resistance Leadership Group
Aflibercept for Radiation Maculopathy
Impact of early versus late Artificial Rupture of Membranes during oxytocin induction of labour on the incidence of chorioamnionitis
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome
Anti-TNF Research study program of the Monoclonal Antibody D2E7
Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non-ST-segment elevation acute myocardial infarction
Anti-TNF Research study program of the Monoclonal Antibody D2E7 4
Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction Cancers
Alliance of Randomized Trials of Medicine Versus Metabolic Surgery in Type 2 Diabetes
Accelerated Mortality On Renal Replacement
Affirming At-Risk Minorities for Success
APSAC Reocclusion Multicenter Study
Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty study
Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort
Antiplatelet therapy for reduction of myocardial damage during angioplasty
Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty study 2
Antiplatelet therapy for reduction of myocardial damage during angioplasty SELECT substudy
Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery study 3
Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty
Antiplatelet therapy for reduction of myocardial damage during angioplasty
Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction
Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin
Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty
Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery study-9 Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting
Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery study-Acute Coronary Syndromes
Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules
Usefulness of preprocedural levels of advanced glycation end products to predict restenosis in patients with controlled diabetes mellitus undergoing drug-eluting stent implantation for stable angina pectoris
Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules substudy
Atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy
Correlation of platelet reactivity and C-reactive protein levels to occurrence of peri-procedural myocardial infarction in patients undergoing percutaneous coronary intervention
Effect of High-Dose Atorvastatin Reload on the Release of Endothelial Progenitor Cells in Patients on Long-Term Statin Treatment Who Underwent Percutaneous Coronary Intervention
Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity predicts Outcome
Atorvastatin for Reduction of MYocardial Damage During Angioplasty
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Treatment of PH With Angiotensin II Receptor Blocker and Neprilysin Inhibitor in HFpEF Patients With CardioMEMS Device
Analyzing data, Recognizing excellence and Optimmizing outcome CDK research initiative
Study of ARO-AAT in Patients With Alpha-1 Antitrypsin Deficiency Associated Liver Disease (AATD)
Antibiotic prescribing rate after optimal near-patient C-reactive protein testing in acutely ill children presenting to ambulatory care
Effect of Rimonabant on Glycemic Control in Insulin-Treated Type 2 Diabetes
A Randomized tRial of Expedited transfer to a cardiac arrest center for non-ST elevation out-of-hospital cardiac arrest
Adjunctive rifampicin for Staphylococcus aureus bacteraemia
Advanced Reperfusion Strategies for Refractory Cardiac Arrest
Amiodarone in out-of-hospital Resuscitation of REfractory Sustained ventricular Tachyarrhythmia
Amsterdam resuscitation study
AngioRad Radiation for RESTenosis
Expedited transfer to a cardiac arrest centre for non-ST-elevation out-of-hospital cardiac arrest
Peripheral Arterial Disease
Aggressive Risk factor REduction STudy for Atrial Fibrillation
Terminal Weaning of Mechanical Ventilation or Extubation in Anticipation of Death in the Intensive Care Unit
At-Risk Registers In Severe Asthma
A clinical risk score for prediction of stent thrombosis
A Randomized Trial of Induction Versus Expectant Management - Trial on Elective Induction and Obstetric Outcomes in Term Nulliparous Patients
Aspirin to Reduce Risk of Initial Vascular Events
Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy
Absolute Risk ReductiOn in systematic revieWs
AntiRetroviral Research fOr Watoto
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors